p53 Codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women

European Journal of Cancer Prevention

Volumn 9, Issue 2, 2000, Pages 113-118

  Agorastos, T ^a,b   Lambropoulos, A F ^b   Constantinidis, T C ^c   Kotsis, A ^b   Bontis, J N ^a  

^a 2nd Univ Clin of Obstet and G   (Greece)

^b Department of Biology and Genetics ^*  (Greece)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Cervical cancer; CIN; HPV; p53 polymorphism

Indexed keywords

PROTEIN P53;

ARTICLE; BRAZIL; CANCER RISK; CODON; CONTROLLED STUDY; CORRELATION FUNCTION; DNA POLYMORPHISM; EUROPE; GREECE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; ARGININE; CERVICAL INTRAEPITHELIAL NEOPLASIA; CODON; CONFIDENCE INTERVALS; FEMALE; GENES, P53; GENOTYPE; GREECE; HUMANS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; UTERINE CERVICAL NEOPLASMS;

EID: 0034113170     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200004000-00007     Document Type: Article

References (20)

1. Beckman G, Birgander R, Sjalander A, et al. (1994). Is p53 polymorphism maintained by natural selection? Hum Hered 44: 266-70.
2. Bosch FX, Munoz N, de Sanjose S, et al. (1994). Importance of the human papillomavirus endemicity in the incidence of cervical cancer: an extension of the hypothesis on sexual behavior. Cancer Epidemiol Biomarkers Prev 3: 375-379.
3. Bosch FX, Manos MM, Munoz N, et al., and the International Biological Study on Cervical Cancer (IBSCC) Study Group (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87: 796-802.
4. Hayes VM, Hofstra RMW, Buys CHCM, Hollema H, van der Zee AGJ (1998). Homozygous arginine-72 in wild type p53 and risk of cervical cancer. Lancet 352: 1756.
5. Helland A, Langeroed A, Johnsen H, et al. (1998). p53 polymorphism and risk of cervical cancer. Nature 396: 530-1.
6. Hildesheim A, Schiffman M, Brinton LA, et al. (1998). p53 polymorphism and risk of cervical cancer. Nature 396: 531-2.
7. Josefsson AM, Magnusson PKE, Ylitalo N, et al. (1998). p53 polymorphism and risk of cervical cancer. Nature 396: 531.
8. Klaes R, Ridder R, Schaefer U, et al (1999). No evidence of p53 allele-specific predisposition in human papillomavirus-associated cancer. J Mol Med 77: 299-302.
9. Lange K (1997). Mathematical and Statistical Methods for Genetic Analysis. Springer, Berlin.
10. Lanham S, Campbell I, Watt P, Gornall R (1998). p53 polymorphism and risk for cervical cancer. Lancet 352: 1631.
11. Makni H, Franco EL, Kaiano J, et al. (2000). p53 polymorphism in codon 72 and risk of HPV-induced cervical cancer: effect of inter-laboratory variation. Int J Cancer (in press).
12. Minaguchi T, Kanamori Y, Matsushima M, et al. (1998). No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res 58: 4585-6.
13. Park SY, Kang YS, Kim BG, et al. (1995). Loss of heterozygosity on the short arm of chromosome 17 in uterine cervical carcinomas. Cancer Genet Cytogenet 79: 74-8.
14. Rosenthal AN, Ryan A, Al-Jehani RM, et al. (1998). p53 codon 72 polymorphism and risk for cervical cancer in UK. Lancet 352: 871-5.
15. Scheffner M, Werness BA, Huibregtse JM, et al. (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes degradation of p53. Cell 63: 1129-36.
16. Storey A, Thomas M, Kalita A, et al. (1998). Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393: 229-34.
17. To-Figueras J, Gene M, Gomez-Catalan J, et al. (1996). Glutathione-S-transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev 5: 337-42.
18. Weston A, Godbold JH (1997). Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis. Envirom Health Perspect 105 (suppl 4): 919-26.
19. Yamashita T, Yaginuma Y, Saitoh Y, et al. (1999). Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix. Carcinogenesis 20: 1733-6.
20. Zehbe I, Voglino G, Wilander E, et al. (1999). Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet 354: 218-9.